Fertility and Sterility
Volume 94, Issue 3 , Pages 946-951, August 2010

Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota

Received 4 February 2009; received in revised form 22 April 2009; accepted 4 May 2009. published online 12 June 2009.

Objective

To determine the efficacy of a short P-in-oil protocol (11 days) in comparison with a traditional P-in-oil protocol (6 weeks) after IVF and embryo transfer.

Design

Prospective randomized, controlled trial.

Setting

Tertiary referral reproductive medicine unit.

Patient(s)

The first IVF-embryo transfer cycle of women ≤37 years old.

Intervention(s)

Either the standard protocol, 50 mg of IM P-in-oil daily for 6 weeks (group 1) or the study protocol, 50 mg of IM P-in-oil daily for 11 days (group 2).

Main Outcome Measure(s)

Clinical pregnancy, ongoing pregnancy, and live birth rates.

Result(s)

One hundred one patients were enrolled (48 in group 1, 53 in group 2). Mean age (31.8 years vs. 32.7 years) and reasons for infertility were not different between the groups. Despite higher embryo quality in group 1 than in group 2 (60.3 vs. 51.6), clinical (63.0% vs. 62.7%) and ongoing (58.7% vs. 51.0%) pregnancy rates (PR) were not significantly different. Live birth rates (52.2% vs. 49.0%) were not significantly different.

Conclusion(s)

Pregnancy and live birth rates were not different between the two groups, suggesting that the common practice of lengthy (≥6 weeks) P support of IVF pregnancies may be unnecessary.

Key Words: Luteal phase support, progesterone-in-oil, in vitro fertilization, pregnancy outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 C.S.G. has nothing to disclose. T.C.N. has nothing to disclose. M.A.D. has nothing to disclose.

PII: S0015-0282(09)01072-3

doi:10.1016/j.fertnstert.2009.05.003

Fertility and Sterility
Volume 94, Issue 3 , Pages 946-951, August 2010